Effectiveness and safety of glucocorticoids bridging rituximab in neuromyelitis spectrum disorder.

导出 LinkOut

翻译打印收藏纠错

第一作者： Chunyang,Wang

第一单位： Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin, China.

作者： Chunyang,Wang ^[1] ; Jia,Liu ^[1] ; Xue,Gao ^[1] ; Yi,Shen ^[1] ; Jing,Pan ^[1] ; Shu,Yang ^[1] ; Moli,Fan ^[1] ; Dongmei,Jia ^[1] ; Chao,Zhang ^[2]

作者单位： Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin, China. ^[1] Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin, China; State Key Laboratory of Experimental Hematology, Haihe Laboratory of Cell Ecosystem, Tianjin, China. Electronic address: chaozhang@tmu.edu.cn. ^[2]

关键词 Bridging NMOSD Relapse Rituximab

DOI 10.1016/j.msard.2025.106314

PMID 39923413

发布时间 2025-02-09

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Multiple sclerosis and related disorders

2025年95卷

106314页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Effectiveness and safety of glucocorticoids bridging rituximab in neuromyelitis spectrum disorder.

Multiple sclerosis and related disorders

相似文献

Multiple sclerosis and related disorders

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Effectiveness and safety of glucocorticoids bridging rituximab in neuromyelitis spectrum disorder.

Multiple sclerosis and related disorders

相似文献

Multiple sclerosis and related disorders

相关期刊

检索历史清除